Dialectical behavior therapy for youth at risk for bipolar disorder
Official title: Dialectical Behavior Therapy for Youth With and/or at Familial Risk for Bipolar Disorder: Focus on Predictors and Mediators of Treatment Outcomes
Run by Centre for Addiction and Mental Health · NCT05153382 · Data updated 2026-11-12
This study is testing if dialectical behavior therapy can help young people aged 13 to 23 who are at risk for bipolar disorder learn important skills to manage their emotions and relationships.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 13 Years to 23 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Centre for Addiction and Mental Health Academic / other |
| Locations | 1 site (Toronto, Ontario) |
| Status | Recruiting |
| Started | November 1, 2021 |
| Main results expected | November 2028 |
| Study ends | November 2029 |
| Registry record updated | October 1, 2026 |
| Trial ID | NCT05153382 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English-speaking youth aged 13 to 23 with a diagnosis of bipolar disorder or a familial history of the disorder.
✕Probably not a fit
Patients who do not meet the age criteria or do not have a diagnosis of bipolar disorder or familial risk may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of dialectical behavior therapy (DBT) for youth aged 13 to 23 who are diagnosed with bipolar disorder or have a familial risk for the condition. Over the course of one year, participants will engage in biweekly DBT skills training and individual therapy sessions, focusing on essential skills such as mindfulness, emotion regulation, and interpersonal effectiveness. The study aims to assess predictors and mediators of treatment outcomes, building on previous research conducted by the University of Pittsburgh and Sunnybrook Health Sciences Centre. Trained therapists will deliver the intervention, with family involvement encouraged but not mandatory.
Why it matters
Potential benefit: If successful, this therapy could significantly improve emotional regulation and coping skills in youth at risk for bipolar disorder, potentially reducing the severity of their symptoms.
How similar studies have gone: Previous studies have shown promise in adapting DBT for youth with bipolar disorder, indicating a potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1\) English-speaking; 2) Age 13 years, 0 months to 23 years, 11 months; 3) Meet diagnostic criteria for BD by KSADS-PL (\< 20 years of age) or SCID-5-RV (\> 20 years of age) OR have a biological parent/sibling with BD (type I or II) confirmed via KSADS-PL or SCID-5-RV; 4) If BD-I, taking ≥1 mood stabilizing medication (i.e., antimanic anticonvulsant, antipsychotic, and/or lithium); 5) Followed by a psychiatrist who provides ongoing care; 6a) At least 1 suicide attempt in the past year (actual, interrupted, and/or aborted as measured by the C-SSRS) OR at least 1 preparatory act or behavior in the past year as measured by the C-SSRS OR non-suicidal self-injurious (NSSI) behaviors in the past 3 months (as measured by the C-SSRS) -OR- 6b) Meet youth threshold for at least 2 impulsive behavior categories on question #4 from the SIDP-IV or 1 category is identified as severe (through case discussion that will focus on level of risk, persistence, and impairment); 7) Able and willing to give informed consent/assent to participate. Exclusion Criteria: 1\) Evidence of mental retardation, moderate to severe autism spectrum disorder, or organic central nervous system disorder by the K-SADS-PL (\< 20 years of age), parent report, medical history, or school records that would interfere with active participation in DBT; 2) A life-threatening medical condition requiring immediate treatment; 3) Current victim of sexual or physical abuse; 4) Current substance use disorder other than mild cannabis or alcohol use disorder.
Where it's running
-
Centre for Addiction and Mental Health
Toronto, Ontario, Canada Recruiting
Study contacts
- Principal investigator: Benjamin I Goldstein, MD, PhD — Centre for Addiction and Mental Health
- Study coordinator: Jessica Roane, MSW
- Email: jessica.roane@camh.ca
- Phone: 416-535-8501
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of comorbidity on people with severe mental illness
This study tests how having both alcohol/substance use and a severe mental illness affects hospitalizations, medications, and social participation among adults followed at a mental health center.
-
Venous Tourniquet with Low-Dose Sugammadex vs Arterial Tourniquet for Seizure Monitoring During ECT
40 patients undergoing ECT will have a venous tourniquet on one arm and an arterial tourniquet on the other to see which method better reveals motor seizures.
-
7T MRI and visual perception markers for severe mood and psychotic disorders
This project tests whether 7‑tesla MRI scans combined with visual perception tests can identify brain markers linked to diagnosis and treatment outcomes in adults with major depressive disorder, bipolar disorder, or schizophrenia.
-
Emotional Eating, Sleep Quality, Mental State, and Metabolic Syndrome in Psychiatric Patients
This study tests how mood, sleep, and emotional eating relate to metabolic syndrome in people with schizophrenia or bipolar disorder.
-
À deux, c'est mieux — group program to improve romantic relationships for young adults with severe mental illness
This program will try a 12-week, small-group course to help single adults with severe mental illness build skills for dating, communication, and closer social relationships.
-
Brenipatide for adults with bipolar disorder (RENEW-Bipolar-1)
This trial will test whether adding brenipatide to standard bipolar medications can delay worsening of symptoms in adults with bipolar I or II.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.